News

CEE to Host STEM Lyceums Events for Students

McLean, Va. – The Center for Excellence in Education (CEE) announces its spring 2022 schedule of virtual science, technology, engineering, and mathematics (STEM) Lyceums events for high school students.

CEE’s STEM Lyceums are free monthly virtual meetings that will engage high school students in discussion and exploration of STEM concepts and unique STEM career pathways, provided at no cost to schools or students. Students will interact with STEM professionals and fellow students, both national and international. Meetings will foster critical thinking skills, encourage excitement for science, and prepare students to enter STEM careers. An overview of CEE’s Lyceums is posted on YouTube.

Upcoming STEM Lyceums events:

  • CEE will host a STEM Lyceums kickoff on Thursday, February 24, 2022, from 4-5 p.m. ET. Learn more about this exciting program and meet Laura-Ashley Alegbeleye, Manager, STEM Lyceums.
  • On Tuesday, March 22, 2022, from 5-6 p.m. ET the topic is genomics with guest speakers Dr. Tshaka Cunningham, Co-Founder & Chief Scientific Officer at Polaris Genomics Inc. and Dr. Janina Jeff, Staff Bioinformatics Scientist at Illumina and Host of ‘In Those Genes’ podcast.
  • On Wednesday, April 20, 2022, from 5-6 p.m. ET the topic is clean/renewable energy with guest speakers Paula Sanjines, Senior Wastewater Treatment Technologist at Jacobs and Jeffery Sampson, Facility Engineering and Maintenance Manager at Dominion Energy.
  • On Wednesday, May 25, 2022, from 5-6 p.m. ET the topic is nuclear engineering with guest speakers Dr. Neil Todreas, Professor of Nuclear Science and Engineering, and Professor of Mechanical Engineering (Emeritus) at MIT and Robin Penley, Systems Modeling and Simulation Engineer at Newport News Shipbuilding.
  • On Wednesday, June 8, 2022, from 5-6 p.m. ET the topic is Internet of Things (IoT) in healthcare (smart devices) with guest speaker Dr. Steve Hershman, Director of mHealth at Stanford University.

Register for all or any of these events for free online. All the events take place via Zoom.

CEE recently announced it will partner with Virginia Bio to establish and sponsor STEM Lyceums in Virginia’s rural and urban high schools to provide information and hands-on activities that encourage STEM studies and careers in science and technology. The United Negro College Fund and the Urban League of Hampton Roads will also partner in taking this project beyond Virginia to high schools throughout the U.S.

The STEM Lyceums program is managed by Laura-Ashley Alegbeleye, who graduated with a B.S. in Chemical Engineering from Worcester Polytechnic Institute (WPI) and an M.A. in Teaching from Loyola University Maryland. She comes to CEE after working eight years as a high school STEM educator. Prior to working in STEM education, Laura-Ashley worked in industry as an Application Engineer.

“CEE’s STEM Lyceums promise to bring life-changing opportunities to rural and urban students,” said Joann DiGennaro, President of CEE. “Thanks to the Center’s supporters, STEM Lyceums are cost-free to participants.”

Companies and organizations interested in supporting this innovative program are encouraged to contact CEE’s Development office at (703) 448-9062.

Read more here.

Recent News

06/11/2026

Adial Pharmaceuticals Announces Acquisition of Azora Therapeutics and up to $64 Million Financing

Adial Pharmaceuticals, Inc. (Nasdaq: ADIL) (“Adial” or the “Company”) today announced that it has acquired Azora Therapeutics, Inc. (“Azora”), a biopharmaceutical company developing treatments for serious inflammatory diseases. The acquisition brings Azora’s lead asset AT177, a proprietary colon‑targeted aryl hydrocarbon receptor (AhR) agonist designed to enable localized activation with limited systemic exposure, into Adial’s pipeline.

06/11/2026

Luna Labs Launches 3 Waves Venture Spinout to Commercialize Advanced Vestibular Stimulation Technology

Luna Labs today announced the launch of 3 Waves, Inc. (“3Waves”), a dual-use spinout company that was established to commercialize advanced virtual and mixed reality technologies for defense, commercial simulation, and medical applications. As part of the spinout, 3Waves and Mayo Clinic executed an exclusive license to support the development of next-generation vestibular stimulation systems

06/02/2026

TearSolutions Receives FDA Orphan Drug and Fast Track Designations for Lacripep® in Neurotrophic Keratitis and Initiates Phase 2 Clinical Trial with First Patients Dosed

TearSolutions, Inc. (“TearSolutions”), a clinical-stage biotechnology company developing novel ophthalmic therapeutics, today announced receiving Food and Drug Administration (FDA) Orphan Drug (ODD) and Fast Track Designations for Lacripep in Neurotrophic Keratitis (NK) and initiating a Phase 2 clinical trial with first patients dosed. The FDA’s ODD provides incentives, including tax credits for clinical testing and